For the 2018 awards, we've widened the remit of the coveted Researchers Choice award to include suppliers from across numerous reagent types.
Bio-Techne really stood out to our judges in this category. The company, which trades under a number of brands including R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, BiosPacific, Cliniqa and ACD, received numerous nominations from researchers around the world, all outlining the excellent quality of products and standards of service they have experienced. Nominees said:
Dr Andrew Chalmers, Founder of CiteAb, said: “This is always one of the most competitive categories in the awards, but we’ve never seen one company get quite so many nominations as Bio-Techne did this year. Clearly the company has a very loyal customer base, earned through providing excellent products. Congratulations to Bio-Techne!”
Explore additional categories featuring in the 2018 CiteAb Awards.
Highlighting an outstanding individual who has made a significant impact in the reagent sector.
Shedding light on the reagent supplier that researchers have been most impressed by in 2017.
Recognising the most exciting new antibody validation initiative in the sector from 2017.
Celebrating reagents or instruments that are set to change the sector.
Rewarding the company with the most antibody citations during 2017.
An exciting award for the company with the largest percentage increase in citations during 2017.
A new category recognising the chemical probes supplier with the most citations during 2017.
A new category, recognising the chemical probes company with the largest percentage increase in citations in 2017.
Awarding the company that has secured the most custom antibody citations over the past 3 years.
An award to recognise the company with the most citations achieved in the cancer biology market during 2017.
This award recognises the antibody company which has achieved the largest increase in antibody market share over the past five years.
Recognising the most cited flow cytometer instrument during 2017.